1-4 of 4
Hui Wan, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results from the International, Multi-Center, Retrospective B-Holistic Study: Describing Treatment Pathways and Outcomes for Classical Hodgkin Lymphoma

Burhan Ferhanoglu, MD, Tae Min Kim, MD PhD, Amado Karduss, MD, David Brittain, MBBCh, FC Path, Cert Clin Haem, Gayane Tumyan, Mubarak Al Mansour, Marta Zerga, MD, Yuqin Song, MD PhD, Silvia Rivas-Vera, MD, Yok Lam Kwong, MD FRCP, Soon Thye Lim, MBBS, MRCP, Su-Peng Yeh, MD, Arif Abdillah, MD, Zhongwen Huang, Mehul Dalal, PhD, Hui Wan, MD PhD, Mark Hertzberg, MBBS PhDFRACP FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–34.
https://doi.org/10.1182/blood-2020-134885
Published: 2020
Journal Articles

Protocol for an International, Multi-Centre, Retrospective Study to Describe Treatment Pathways, Outcomes and Resource Use in Patients with Multiple Myeloma (INTEGRATE)

Su-Peng Yeh, MD, Fahad Alsharif, MD DIM, MB ChB, Meral Beksac, MD, Wenming Chen, PhD, Dorotea Fantl, MD, Tatiana Mitina, MD PhD, Estelle Verburgh, MBChB, M MDInt, FCPSA, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Kwang-Wei Wu, MD, Zijing Zhang, PhD, Hui Wan, MD PhD, Kihyun Kim, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5577.
https://doi.org/10.1182/blood-2019-122732
Published: 2019
Journal Articles

Interim Analysis Results from an International, Multi-Centre, Non-Interventional Retrospective Study to Describe Treatment Pathways, Outcomes, and Resource Use in Patients with Classical Hodgkin Lymphoma: B-CD30+ Hodgkin Lymphoma International Multi-Centre Retrospective Study of Treatment Practices and Outcomes (B-HOLISTIC)

Burhan Ferhanoglu, MD, Tae Min Kim, Gayane Tumyan, DMSc, MD PhD, Su-Peng Yeh, MD, David Brittain, MBBCh, FC Path, Cert Clin Haem, Amado Karduss, MD, Yok Lam Kwong, MD FRCP, Soon Thye Lim, MBBS, MRCP, FAMS, Mubarak Al Mansour, MD, Silvia Rivas-Vera, MD, Yuqin Song, MD PhD, Marta Zerga, MD, Julie Blair, PhD MD MPhil, Mehul Dalal, PhD, Hui Wan, MD PhD, Mark Hertzberg
Journal: Blood
Blood (2018) 132 (Supplement 1): 2917.
https://doi.org/10.1182/blood-2018-99-111146
Published: 2018
Journal Articles

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Weijun Fu, MD PhD, Jin Lu, Jie Jin, MD PhD, Yan Xu, MD, Depei Wu, Dao-bin Zhou, MD, Xiaoyan Ke, Xin Du, MD PhD, Xiequn Chen, MD PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Kihyun Kim, MD PhD, Junmin Li, MD PhD, Jae Hoon Lee, MD PhD, Jing Liu, PhD, Yeow Tee Goh, MBBS, MD, Kwang-Wei Wu, MD, Hui Wang, MD, Guohui Liu, PhD, Tomas Skacel, MD PhD, Hui Wan, MD PhD, Deborah Berg, RN, MSN
Journal: Blood
Blood (2018) 132 (Supplement 1): 5637.
https://doi.org/10.1182/blood-2018-99-116844
Published: 2018